Isolation by continuous density gradient centrifugation and characterization of bone marrow cells active in prolonging allograft survival in antilymphocyte serum (ALS)-treated mice.
作者信息
De Fazio S R, Kowolenko M, Monaco A P, Gozzo J J
机构信息
College of Pharmacy and Allied Health, Northeastern University, Boston, MA 02115.
出版信息
Transplant Proc. 1987 Feb;19(1 Pt 1):547-8.
PMID:2856297
Abstract
摘要
相似文献
1
2
Augmentation by donor bone marrow of the survival of neonatal skin transplants to ALS-treated recipients.
Transplant Proc. 1987 Feb;19(1 Pt 1):470-1.
3
Specificity requirement of donor bone marrow cells that prolong allograft survival: implications for a veto cell mechanism of action.
Transplant Proc. 1995 Feb;27(1):171-3.
4
Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
Transplant Proc. 1987 Feb;19(1 Pt 2):1409-10.
5
Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice.
Transplant Proc. 1978 Jun;10(2):379-87.
6
Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells.
J Immunol. 1985 Nov;135(5):3034-8.
7
Fractionated bone marrow: use of a lymphocyte containing fraction for skin allograft prolongation in antilymphocyte serum (ALS) treated mice.
Transplant Proc. 1981 Mar;13(1 Pt 1):592-5.
8
Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
Transplant Proc. 1993 Feb;25(1 Pt 1):717-8.
9
Prolongation of graft survival in ALS-treated mice by donor-specific bone marrow. Density gradient fractionation of the active bone marrow cells.
Transplantation. 1987 Apr;43(4):564-70. doi: 10.1097/00007890-198704000-00022.
10
In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
Transplant Proc. 1973 Mar;5(1):853-6.
Zotero 插件